Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate Risk-Reduction Trial
NCT00307398Phase 3Terminated
- Sponsor
- Alcon Inc.
- Start
- Mar 2004
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anecortave in age-related macular degeneration (AMD), sponsored by Alcon Inc.. Started Mar 2004; status: terminated.
02
Drugs
anecortave
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00307398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307398.